Mercapturate pathway metabolites of sotorasib, a covalent inhibitor of KRASG12C, are associated with renal toxicity in the Sprague Dawley rat

The mercapturic acid pathway

(2020) Patrick E. Hanna et al.   CRITICAL REVIEWS IN TOXICOLOGY

KRASG12C Inhibition with Sotorasib in Advanced Solid Tumors

(2020) David S. Hong et al.   NEW ENGLAND JOURNAL OF MEDICINE

Relationship of MATE1 inhibition and cytotoxicity in nephrotoxicity: application for safety evaluation in early drug discovery

(2019) Kimio Tohyama et al.   TOXICOLOGICAL SCIENCES

The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity

(2019) Jude Canon et al.   NATURE

Discovery of a Covalent Inhibitor of KRASG12C (AMG 510) for the Treatment of Solid Tumors

(2019) Brian A. Lanman et al.   JOURNAL OF MEDICINAL CHEMISTRY

Pharmacology behind Common Drug Nephrotoxicities

(2018) Mark A. Perazella   Clinical Journal of the American Society of Nephrology

KRAS oncogene in non-small cell lung cancer: clinical perspectives on the treatment of an old target

(2018) Marta Román et al.   Molecular Cancer

Nephrotoxicity and Renal Pathophysiology: A Contemporary Perspective

(2018) Lillie M A Barnett et al.   TOXICOLOGICAL SCIENCES

Efavirenz reduces renal excretion of lamivudine in rats by inhibiting organic cation transporters (OCT, Oct) and multidrug and toxin extrusion proteins (MATE, Mate)

(2018) Martina Ceckova et al.   PLoS One

AACR Project GENIE: Powering Precision Medicine through an International Consortium

(2017)   Cancer Discovery

Hepatic Enzyme Induction

(2010) Robert R. Maronpot et al.   TOXICOLOGIC PATHOLOGY

Mechanisms of Cisplatin Nephrotoxicity

(2010) Ronald P. Miller et al.   Toxins

Ras oncogenes: split personalities

(2008) Antoine E. Karnoub et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY